Stock Comparison
TEVA vs ZTS
Teva Pharma Industries Ltd ADR and Zoetis Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$38.67B
$31.90B
P/E (TTM)
24.8
12.5
Forward P/E
16.0
11.1
Price/Sales
2.2
3.4
Price/Book
4.7
9.9
EV/EBITDA
16.3
9.7
Dividend Yield
—
2.61%
Profitability
Net Margin
9.02%
28.00%
Operating Margin
19.20%
36.60%
Return on Equity
21.60%
67.70%
Return on Assets
6.38%
15.50%
Growth (YoY)
Revenue Growth
2.30%
2.90%
Earnings Growth
72.20%
6.00%
Price & Risk
Beta
0.9
0.7
52-Week High
$37.35
$159.30
52-Week Low
$14.99
$72.38
Analyst Target
$40.90
$124.59
Compare TEVA and ZTS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.